載入...
Combination Testing of Cediranib (AZD2171) against Childhood Cancer Models by the Pediatric Preclinical Testing Program
BACKGROUND: Cediranib (AZD2171) is a potent small molecule inhibitor of vascular endothelial growth factor VEGF receptors. Cediranib has demonstrated single agent activity in several adult cancers and is being studied in combination with standard cytotoxic agents in multiple disease settings. PROCED...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3253323/ https://ncbi.nlm.nih.gov/pubmed/21538824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.23159 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|